Donna French

Donna French

Director/Board Member chez KORU MEDICAL SYSTEMS, INC.

Fortune : 141 550 $ au 31/03/2024

59 ans
Health Technology
Consumer Services
Health Services

Profil

Donna French is currently an Independent Director at KORU Medical Systems, Inc. and a Vice President-Dosage Form Design & Development at AstraZeneca LP.
Previously, she held the position of Senior Director-Device Development at Genentech, Inc. from 2009 to 2017.
She also worked as a Director at Breckinridge Health, Inc. and as an Executive Director-Drug Delivery Engineering at Amgen, Inc. from 1994 to 2009.
Dr. French holds a doctorate degree from the University of Nebraska and an undergraduate degree from Albany College of Pharmacy & Health Sciences.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2024 59 979 ( 0,13% ) 141 550 $ 31/03/2024

Postes actifs de Donna French

SociétésPosteDébut
KORU MEDICAL SYSTEMS, INC. Director/Board Member 18/05/2021
Corporate Officer/Principal 01/06/2017
Tous les postes actifs de Donna French

Anciens postes connus de Donna French

SociétésPosteFin
Corporate Officer/Principal 01/05/2017
AMGEN INC. Corporate Officer/Principal 01/01/2009
Director/Board Member -
Voir l'expérience en détail de Donna French

Formation de Donna French

University of Nebraska Doctorate Degree
Albany College of Pharmacy & Health Sciences Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Donna French

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
AMGEN INC.

Health Technology

KORU MEDICAL SYSTEMS, INC.

Health Technology

Entreprise privées3

Health Technology

Health Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Donna French